Occurrence of Candidemia in Patients with COVID-19 Admitted to Five ICUs in France.

COVID-19 Candida SARS-CoV-2 candidemia candidiasis fungal infection fungemia

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
28 Jun 2022
Historique:
received: 07 05 2022
revised: 16 06 2022
accepted: 24 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Whether severe COVID-19 is by itself a significant risk factor for the development of candidemia currently remains an open question as conflicting results have been published. We aim to assess the occurrence of candidemia in patients with severe COVID-19 admitted to the intensive care unit (ICU). We conducted a retrospective study on patients with severe SARS-CoV-2-related pneumonia admitted to 5 ICUs in France who were specifically screened for fungal complications between March 2020 and January 2021. The study population included a total of 264 patients; the median age was 56 years old and most of them were male (n = 186; 70.5%) and immunocompetent (n = 225; 87.5%), and 62.7% (n = 153/244) were on extracorporeal membrane oxygenation support. Microbiological analysis included 4864 blood culture samples and beta-glucan test performed on 975 sera. Candidemia was diagnosed in 13 (4.9%) patients. The species involved were mainly

Identifiants

pubmed: 35887435
pii: jof8070678
doi: 10.3390/jof8070678
pmc: PMC9320616
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Respir Med. 2022 Feb;10(2):180-190
pubmed: 34843666
Sci Rep. 2021 Oct 13;11(1):20281
pubmed: 34645905
Clin Infect Dis. 2021 Nov 2;73(9):e2838-e2839
pubmed: 33124650
Mycoses. 2021 Jun;64(6):634-640
pubmed: 33608923
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Mycoses. 2022 Jun;65(6):613-624
pubmed: 35441748
Infect Control Hosp Epidemiol. 2013 Jan;34(1):24-30
pubmed: 23221189
Mycoses. 2021 Sep;64(9):1083-1091
pubmed: 34085319
J Fungi (Basel). 2022 Mar 16;8(3):
pubmed: 35330307
Front Immunol. 2021 Jun 09;12:686240
pubmed: 34177935
Crit Care Med. 2011 Apr;39(4):665-70
pubmed: 21169817
Crit Care. 2020 Mar 18;24(1):109
pubmed: 32188500
Open Forum Infect Dis. 2021 Nov 16;8(12):ofab510
pubmed: 34877364
J Hosp Infect. 2021 Jan;107:95-97
pubmed: 33217490
Clin Microbiol Infect. 2020 Nov;26(11):1582-1584
pubmed: 32619736
Am J Respir Crit Care Med. 2021 Feb 1;203(3):307-317
pubmed: 33480831
J Mycol Med. 2021 Sep;31(3):101139
pubmed: 33965885
J Infect. 2017 Jul;75(1):59-67
pubmed: 28366686
Mycopathologia. 2020 Apr;185(2):257-268
pubmed: 31983047
Sci Immunol. 2021 Aug 19;6(62):
pubmed: 34413139
Front Immunol. 2021 Jul 14;12:708149
pubmed: 34335624
Antimicrob Agents Chemother. 2021 Feb 16;:
pubmed: 33593841

Auteurs

Marion Blaize (M)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Audrey Raoelina (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Dimitri Kornblum (D)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Laure Kamus (L)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Alexandre Lampros (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Marie Berger (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Sophie Demeret (S)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Réanimation Neurologique, F-75013 Paris, France.

Jean-Michel Constantin (JM)

Sorbonne Université, GRC 29, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Département d'Anesthésie Réanimation, F-75013 Paris, France.

Antoine Monsel (A)

Sorbonne Université, INSERM, Immunology Immunopathology Immunotherapy (I3), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Département d'Anesthésie Réanimation, F-75013 Paris, France.

Julien Mayaux (J)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Réanimation Médicale, F-75013 Paris, France.

Charles-Edouard Luyt (CE)

Sorbonne Université, INSERM, Institute of Cardiometabolism and Nutrition, Assistance Publique-Hôpitaux de Paris (APHP), Médecine Intensive Réanimation-Institut de Cardiologie, F-75013 Paris, France.

Renaud Piarroux (R)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Arnaud Fekkar (A)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier La Pitié-Salpêtrière, Parasitologie Mycologie, F-75013 Paris, France.

Classifications MeSH